This site is intended for healthcare professionals
Managing Osteoarthritis-associated Pain

Emerging therapies

Read time: 20 mins
Current standard of care treatment for osteoarthritis (OA) pain does not provide satisfactory pain relief for many patients. Emerging therapies currently under clinical trial investigation target both the nociceptive and inflammatory pathways that promote OA pain.

Pharmacological strategies for managing pain in OA include paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs), intra-articular treatments and opioid analgesics for severe cases. These treatments are often inadequate, particularly in older patients that are less able to deal with adverse events or who possess contraindicated comorbidities. 

Adverse events include paracetamol-induced hepatotoxicity, gastrointestinal toxicities from NSAIDs and the risk of falls, delirium and dependency from opioids1. There is consequently a medical need for long-lasting, effective and tolerable treatments for OA pain.

Register free for full access to


Developed by EPG Health for Medthority. This content has been developed independently of the sponsors Pfizer and Lilly, who have had no editorial input into the content. EPG Health received educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.